Twist Bioscience Corporation (TWST) Stock Forecast: Should Investors Consider After 3.22% Rise?

If you’re on the hunt for stocks to watch today, Twist Bioscience Corporation (NASDAQ:TWST) is a stock to give close attention to. The company shares are trading 3.22% or 0.93 points up from last closing price of $28.9, reaching $29.83 at last check. The TWST share price has risen in 3 of the last 5 days and is up 23.29% over the past week. It will be exciting to see whether the stock manages to continue increasing or take a minor break for the next few days. The move came on weak volume too with far less shares changing hands than in a normal session. Trading activity as of this writing weakened by -15,605 shares, and in total 307495 shares valued at $9.173 million were seen changing hands compared with 323100 shares valued at $9.338 million recorded at the previous session. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes in TWST stock for the next couple of days.

Twist Bioscience Corporation (TWST) shares have notched a 3-month gain of about 23.29%, but has still advanced 25.16% year to date. By comparison, the stock sank 0% over the past 12 months, while it slipped -1.16% over the 1 month. The company’s market cap is around $918.15M, with its short interest ratio standing at 8.07%.

In the current trading session for TWST, the stock witnessed two major price actions, it rose to a high of $29.94 and was down as much as $28.8 at one point. The high recorded is very low when compared to their 52-week high which is $12.38. The 52-week high is now at -17.25 distance from current price. Their recent low of $35.95 represents a 140.31% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for TWST is $34.33, this is below the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.

The stock of Twist Bioscience Corporation earned $-3.78 per share in the trailing 12 months and has a P/E ratio of -7.89. You can compare it with that of similar companies in its industry to get a sense of whether the stock you’re looking to purchase is overvalued or undervalued. Its current price to earnings ratio is lower than the ones recorded by the industry which is 30.46 and lower compared to the sector’s average of 30.52. When the P/E ratio is low let’s say below 1.0, then the stock price is considered a good value. TWST also has P/S multiple of 20.12. This is greater versus the 12 month P/S ratios of other companies in the same indutry. The peer average price to sales ratio is 2.34x.

TWST‘s last price was up 16.03% as compared to the average trading price of 50 days recorded at $25.71 while enlarging the period to 200 trading days, the average closing price was $29.59. At present, there are 31.77 million in the total number of common shares owned by the public and among those 26.67 million shares have been available to trade. The percentage of shares being held by the company management was 2.7% while institutions stake was 54%. The company has generated negative returns on equity over the last 12 months (-168.4%). It managed to keep its gross profit margin at 6.2% over the past 12 months.

When assessing the full upside of the TWST stock, there is another set of technicals that should be looked into and considered. Its 3.35% gain from moving average of $28.86 has brought about a positive sentiment when calculated over the last 20 days. The market has allocated a beta of 0 to the stock. With the beta been less than one, this implies that the company shares are theoretically less volatile than the market, something that the traders definitely are keeping an eye on.

Most of the analysts surveyed by Thomson/First Call think quite highly of Twist Bioscience Corporation — 3 analysts rate the stock as a buy with another 0 rating it strong buy. There are 1 analysts who maintain a hold rating for the stock, with 0 giving it a sell rating. Analysts arrived at a 12-month price target of $26.325 on shares of Twist Bioscience Corporation (NASDAQ:TWST), which corresponds to 12.07% downside potential than its current market price of $29.83 and implies potential despite the recent advance in the price. However, their current target price has fallen from $26.325 a month ago and is down handily from the consensus target of $26.325 a quarter ago.